This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1996 Jul-Aug;46(4):225-44.

doi: 10.3322/canjclin.46.4.225.

Vaccine therapy for malignant melanoma

D L Morton¹, A Barth

Affiliations

PMID: 8673695
DOI: 10.3322/canjclin.46.4.225

Free article

Review

Vaccine therapy for malignant melanoma

D L Morton et al. CA Cancer J Clin. 1996 Jul-Aug.

Free article

. 1996 Jul-Aug;46(4):225-44.

doi: 10.3322/canjclin.46.4.225.

Authors

D L Morton¹, A Barth

Affiliation

¹ John Wayne Cancer Institute, Saint John's Hospital and Health Center, Santa Monica, California, USA.

PMID: 8673695
DOI: 10.3322/canjclin.46.4.225

No abstract available

PubMed Disclaimer

Similar articles

[Adjuvant interferon-alpha therapy of malignant melanoma. Position of the Dermatologic Oncology Working Group].
Hauschild A, Dummer R, Garbe C, Kaufmann R, Schadendorf D, Soyer HP, Stadler R, Tilgen W. Hauschild A, et al. Hautarzt. 1998 Mar;49(3):167-9. doi: 10.1007/s001050050722. Hautarzt. 1998. PMID: 9565782 German. No abstract available.
Does adjuvant vaccine therapy really have activity in malignant melanoma?
Wheatley K, Ives NJ, Lorigan P. Wheatley K, et al. J Clin Oncol. 2007 Oct 10;25(29):4693; author reply 4693-5. doi: 10.1200/JCO.2007.13.3389. J Clin Oncol. 2007. PMID: 17925569 No abstract available.
Phase II study of interferon alpha-2a and dacarbazine in advanced melanoma.
Bajetta E, Negretti E, Giannotti B, Brogelli L, Brunetti I, Sertoli MR, Bernengo MG, Sofra MC, Maifredi G, Zumiani G, et al. Bajetta E, et al. Am J Clin Oncol. 1990 Oct;13(5):405-9. doi: 10.1097/00000421-199010000-00008. Am J Clin Oncol. 1990. PMID: 2220660 Clinical Trial.
Immunotherapy for malignant melanoma with a tumor cell vaccine.
Slingluff CL Jr, Seigler HF. Slingluff CL Jr, et al. Ann Plast Surg. 1992 Jan;28(1):104-7. doi: 10.1097/00000637-199201000-00026. Ann Plast Surg. 1992. PMID: 1642395 Review.
[Interferon therapy in malignant melanoma].
Kokoschka EM, Micksche M. Kokoschka EM, et al. Wien Med Wochenschr. 1993;143(16-17):441-2. Wien Med Wochenschr. 1993. PMID: 8273369 Review. German.

See all similar articles

Cited by

A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells.
Qiu L, Li J, Yu S, Wang Q, Li Y, Hu Z, Wu Q, Guo Z, Zhang J. Qiu L, et al. Oncotarget. 2015 Mar 10;6(7):5195-203. doi: 10.18632/oncotarget.2908. Oncotarget. 2015. PMID: 25760071 Free PMC article.
Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell.
Wang Q, Zhang J, Guo Z. Wang Q, et al. Bioorg Med Chem. 2007 Dec 15;15(24):7561-7. doi: 10.1016/j.bmc.2007.09.005. Epub 2007 Sep 12. Bioorg Med Chem. 2007. PMID: 17892942 Free PMC article.
A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.
Batliwalla FM, Bateman BA, Serrano D, Murray D, Macphail S, Maino VC, Ansel JC, Gregersen PK, Armstrong CA. Batliwalla FM, et al. Mol Med. 1998 Dec;4(12):783-94. Mol Med. 1998. PMID: 9990864 Free PMC article. Clinical Trial.
Technical considerations for studying cancer metastasis in vivo.
Welch DR. Welch DR. Clin Exp Metastasis. 1997 May;15(3):272-306. doi: 10.1023/a:1018477516367. Clin Exp Metastasis. 1997. PMID: 9174129 Review. No abstract available.
Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches.
Daniotti JL, Vilcaes AA, Torres Demichelis V, Ruggiero FM, Rodriguez-Walker M. Daniotti JL, et al. Front Oncol. 2013 Dec 19;3:306. doi: 10.3389/fonc.2013.00306. Front Oncol. 2013. PMID: 24392350 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information